Charles Hsu
Experienced in Ependymoma

Dr. Charles Hsu

Radiation Oncology
Banner Health
Banner-University Medical Center Tucson Campus
1625 North Campbell Avenue, 
Tucson, AZ 
Clinical Trials:Currently Recruiting for 2 Trials
Accepting New Patients
Offers Telehealth
Experienced in Ependymoma
Banner Health
Banner-University Medical Center Tucson Campus
1625 North Campbell Avenue, 
Tucson, AZ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

I enjoy mountain biking, cycling, exploring the outdoors and traveling with friends and family. My research interests include improving survival and maintaining quality of life for our cancer patients.

Dr. Hsu is rated as an Experienced provider by MediFind in the treatment of Ependymoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Metastatic Brain Tumor, Pancreaticoduodenectomy, and Thymectomy.

His clinical research consists of co-authoring 39 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Johns Hopkins University School Of Medicine, 2008
Residency
University of California San Francisco, Radiation Oncology, 2013
Specialties
Radiation Oncology
Licenses
Radiology in CA
Board Certifications
American Board Of Radiology
Hospital Affiliations
Banner - University Medical Center Tucson
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Banner-University Medical Center Tucson Campus
1625 North Campbell Avenue, Tucson, AZ 85719
Other Locations
University of Arizona Cancer Center
1891 West Orange Grove Road, Building 1, Tucson, AZ 85704
Banner - University Medical Center Tucson Campus - Banner University Medicine North
3838 North Campbell Avenue, Building 2, Tucson, AZ 85719

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
Enrollment Status: Recruiting
Publish Date: December 17, 2025
Intervention Type: Procedure, Radiation, Drug
Study Drug: Atezolizumab
Study Phase: Phase 2/Phase 3
MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
Enrollment Status: Recruiting
Publish Date: May 25, 2025
Intervention Type: Procedure, Radiation
Study Phase: Phase 3
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Enrollment Status: Active_not_recruiting
Publish Date: November 25, 2025
Intervention Type: Radiation, Drug
Study Drugs: Docetaxel, Gemcitabine, Pemetrexed Disodium, Erlotinib Hydrochloride, Pembrolizumab
Study Phase: Phase 2
STAMP: Surgically Treated Adjuvant Merkel Cell Carcinoma With Pembrolizumab, a Phase III Trial
STAMP: Surgically Treated Adjuvant Merkel Cell Carcinoma With Pembrolizumab, a Phase III Trial
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Procedure, Other, Radiation, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3
Phase III Trial of Stereotactic Radiosurgery (SRS) or Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for Distant Brain Relapse With Brain Metastasis Velocity >/= 4 Brain Metastases/Year
Phase III Trial of Stereotactic Radiosurgery (SRS) or Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for Distant Brain Relapse With Brain Metastasis Velocity >/= 4 Brain Metastases/Year
Enrollment Status: Terminated
Publish Date: June 06, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drug: Memantine
Study Phase: Phase 3
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 17, 2024
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients With Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients With Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide
Enrollment Status: Unknown
Publish Date: June 12, 2023
Intervention Type: Drug, Radiation
Study Drugs: Cisplatin, Etoposide, Carboplatin
Study Phase: Phase 3
View 5 Less Clinical Trials

39 Total Publications

Clinical outcomes for unresectable anaplastic thyroid cancer treated with radiation: Impacts of radiation intent and the percentage of life spent receiving treatment.
Clinical outcomes for unresectable anaplastic thyroid cancer treated with radiation: Impacts of radiation intent and the percentage of life spent receiving treatment.
Journal: Oral oncology
Published: March 04, 2025
View All 39 Publications
Similar Doctors
Baldassarre Stea
Advanced in Ependymoma
Dr. Baldassarre Stea
Pediatrics | Radiation Oncology
Advanced in Ependymoma
Dr. Baldassarre Stea
Pediatrics | Radiation Oncology

Banner-University Medical Center Tucson Campus

1625 North Campbell Avenue, 
Tucson, AZ 
 (4.8 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

I enjoy traveling to other countries to explore different customs, visiting family and meeting new people; spending time with my children and wife cooking Italian meals; gardening and growing fruits and vegetables ( I have a large fig tree, in my yard); mentoring young students and residents; and publishing research articles. Dr. Stea is rated as a Distinguished provider by MediFind in the treatment of Ependymoma. His top areas of expertise are Astrocytoma, Brain Tumor, Glioblastoma, and Melanoma.

Advanced in Ependymoma
Dr. Matthew R. Mcfarlane
Radiation Oncology
Advanced in Ependymoma
Dr. Matthew R. Mcfarlane
Radiation Oncology

Neurological Associates Of Tucson

2450 E River Rd, 
Tucson, AZ 
 (7.6 miles away)
520-795-7750
Experience:
10+ years
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients
Offers Telehealth

Matthew Mcfarlane is a Radiation Oncologist in Tucson, Arizona. Dr. Mcfarlane has been practicing medicine for over 10 years and is rated as an Advanced provider by MediFind in the treatment of Ependymoma. His top areas of expertise are Trigeminal Neuralgia, Meningioma, Primitive Neuroectodermal Tumor (PNET), and Posterior Fossa Tumor. Dr. Mcfarlane is currently accepting new patients.

Experienced in Ependymoma
Dr. Tijana Skrepnik
Radiation Oncology
Experienced in Ependymoma
Dr. Tijana Skrepnik
Radiation Oncology

Neurological Associates Of Tucson

2450 E River Rd, 
Tucson, AZ 
 (7.6 miles away)
520-795-7750
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Tijana Skrepnik is a Radiation Oncologist in Tucson, Arizona. Dr. Skrepnik is rated as an Advanced provider by MediFind in the treatment of Ependymoma. Her top areas of expertise are Metastatic Brain Tumor, Meningioma, Posterior Fossa Tumor, and Primitive Neuroectodermal Tumor (PNET). Dr. Skrepnik is currently accepting new patients.

VIEW MORE EPENDYMOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hsu's expertise for a condition
ConditionClose
    • Distinguished
    • Lung Cancer
      Dr. Hsu is
      Distinguished
      . Learn about Lung Cancer.
      See more Lung Cancer experts
    • Advanced
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Hsu is
      Advanced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • EGFR Positive Lung Cancer
      Dr. Hsu is
      Advanced
      . Learn about EGFR Positive Lung Cancer.
      See more EGFR Positive Lung Cancer experts
    • Large-Cell Lung Carcinoma
      Dr. Hsu is
      Advanced
      . Learn about Large-Cell Lung Carcinoma.
      See more Large-Cell Lung Carcinoma experts
    • Lung Adenocarcinoma
      Dr. Hsu is
      Advanced
      . Learn about Lung Adenocarcinoma.
      See more Lung Adenocarcinoma experts
    • Metastatic Brain Tumor
      Dr. Hsu is
      Advanced
      . Learn about Metastatic Brain Tumor.
      See more Metastatic Brain Tumor experts
    • Nasopharyngeal Carcinoma
      Dr. Hsu is
      Advanced
      . Learn about Nasopharyngeal Carcinoma.
      See more Nasopharyngeal Carcinoma experts
    View All 12 Advanced Conditions
    • Experienced
    • Alveolar Soft Part Sarcoma
      Dr. Hsu is
      Experienced
      . Learn about Alveolar Soft Part Sarcoma.
      See more Alveolar Soft Part Sarcoma experts
    • Anaplastic Thyroid Cancer
      Dr. Hsu is
      Experienced
      . Learn about Anaplastic Thyroid Cancer.
      See more Anaplastic Thyroid Cancer experts
    • Astrocytoma
      Dr. Hsu is
      Experienced
      . Learn about Astrocytoma.
      See more Astrocytoma experts
    • Atypical Teratoid Rhabdoid Tumor (ATRT)
      Dr. Hsu is
      Experienced
      . Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
      See more Atypical Teratoid Rhabdoid Tumor (ATRT) experts
    • Bone Tumor
      Dr. Hsu is
      Experienced
      . Learn about Bone Tumor.
      See more Bone Tumor experts
    • Brain Tumor
      Dr. Hsu is
      Experienced
      . Learn about Brain Tumor.
      See more Brain Tumor experts
    View All 34 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.